Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boehringer Invests $217M to Expand Fremont Mfg. Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Boehringer Invests $217M to Expand Fremont Mfg. Facility

To increase manufacturing capacity by one-third

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Boehringer Ingelheim is investing $217 million to upgrade and expand its Fremont, CA manufacturing facility. This investment will add nearly 300 skilled positions in the area. The site was recently awarded $25.5 million in two separate tax credits from the state, making them the largest award to a pharmaceutical company. The expansion will allow the company to increase its manufacturing capacity by one-third.
 
“The Bay Area is the largest biotech cluster in the world. We are happy to have made Fremont our home and are grateful for the support we have received from the community and the State of California,” said Jens Vogel, president and chief executive officer of Boehringer Ingelheim Fremont, Inc. “We have made a commitment to the region and are excited to continue to invest in the Bay Area and expand our workforce to help increase patient access to high-quality medicines.” 
 
Boehringer’s Fremont facility focuses on manufacturing medicines for immunology, rheumatology and oncology.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics